This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: University of Toronto. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Andrew Martin Lewis: Innovator in STAT5 Inhibition
Introduction
Andrew Martin Lewis is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit specific biological pathways.
Latest Patents
Lewis holds a patent for sulfonamide compounds and their use as STAT5 inhibitors. This patent describes compounds that have the potential to serve as effective inhibitors of the STAT5 protein, which plays a crucial role in various cellular processes.
Career Highlights
Lewis is affiliated with the University of Toronto, where he engages in research that bridges the gap between chemistry and biology. His work focuses on developing innovative solutions to complex medical challenges.
Collaborations
He has collaborated with esteemed colleagues such as Patrick Thomas Gunning and Abbarna A Cumaraswamy, contributing to a rich environment of research and innovation.
Conclusion
Andrew Martin Lewis exemplifies the spirit of innovation in the field of medicinal chemistry, with his work on STAT5 inhibitors paving the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile